Establishment Labs (NASDAQ:ESTA) Stock Price Down 4.1% – Here’s Why

Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) traded down 4.1% during trading on Monday . The stock traded as low as $59.27 and last traded at $60.1030. 224,474 shares traded hands during trading, a decline of 56% from the average session volume of 512,901 shares. The stock had previously closed at $62.65.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Establishment Labs in a report on Monday, December 29th. Mizuho raised their price objective on shares of Establishment Labs from $90.00 to $100.00 and gave the company an “outperform” rating in a research report on Wednesday, February 25th. Stephens boosted their target price on shares of Establishment Labs from $85.00 to $90.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 25th. BTIG Research upped their target price on shares of Establishment Labs from $86.00 to $88.00 and gave the stock a “buy” rating in a research report on Tuesday, February 24th. Finally, Needham & Company LLC increased their price target on shares of Establishment Labs from $84.00 to $86.00 and gave the company a “buy” rating in a research note on Tuesday, February 24th. Six research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Establishment Labs has a consensus rating of “Moderate Buy” and a consensus price target of $86.86.

Establishment Labs Stock Performance

The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of -33.43 and a beta of 0.91. The company has a debt-to-equity ratio of 10.51, a current ratio of 3.04 and a quick ratio of 2.00. The stock has a 50-day moving average of $69.47 and a 200 day moving average of $61.79.

Establishment Labs (NASDAQ:ESTA) last issued its earnings results on Tuesday, February 24th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.22) by $0.13. Establishment Labs had a negative net margin of 24.19% and a negative return on equity of 201.79%. The company had revenue of $64.62 million for the quarter, compared to analyst estimates of $63.80 million. During the same quarter last year, the firm earned ($1.19) EPS. The company’s revenue for the quarter was up 45.2% on a year-over-year basis. On average, analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Insider Activity at Establishment Labs

In related news, Director Quiros Juan Jose Chacon sold 33,925 shares of the stock in a transaction that occurred on Monday, March 23rd. The shares were sold at an average price of $60.39, for a total value of $2,048,730.75. Following the sale, the director directly owned 1,223,579 shares in the company, valued at $73,891,935.81. This trade represents a 2.70% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 11.44% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ESTA. Geode Capital Management LLC boosted its stake in Establishment Labs by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 25,917 shares of the company’s stock worth $1,105,000 after purchasing an additional 299 shares during the period. Patriot Financial Group Insurance Agency LLC increased its holdings in Establishment Labs by 5.8% during the 3rd quarter. Patriot Financial Group Insurance Agency LLC now owns 6,375 shares of the company’s stock worth $261,000 after purchasing an additional 350 shares in the last quarter. Handelsbanken Fonder AB increased its holdings in Establishment Labs by 7.3% during the 4th quarter. Handelsbanken Fonder AB now owns 8,800 shares of the company’s stock worth $641,000 after purchasing an additional 600 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Establishment Labs by 1.8% in the fourth quarter. Swiss National Bank now owns 34,200 shares of the company’s stock valued at $2,492,000 after purchasing an additional 600 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new stake in shares of Establishment Labs in the fourth quarter valued at about $47,000. Institutional investors and hedge funds own 72.91% of the company’s stock.

About Establishment Labs

Establishment Labs Holdings Inc is a global medical technology company specializing in the design, development and manufacture of silicone gel breast implants for aesthetic and reconstructive surgery. The company’s proprietary portfolio is built around patient-focused safety, customization and innovation, offering solutions intended to enhance surgical outcomes and support clinical traceability.

The company’s flagship products fall under the Motiva® brand, which includes a range of ergonomic and round breast implants featuring SilkSurface® texturing and an embedded Q Inside® Safety microtransponder for unique implant identification.